85.61
price down icon3.04%   -2.68
after-market Dopo l'orario di chiusura: 85.70 0.09 +0.11%
loading

Apogee Therapeutics Inc Borsa (APGE) Ultime notizie

pulisher
Apr 24, 2026

APGE stock up as skin disease drug shows sustained 52-week efficacy - MSN

Apr 24, 2026
pulisher
Apr 24, 2026

Apogee Therapeutics, Inc. ($APGE) CEO 2025 Pay Revealed - Quiver Quantitative

Apr 24, 2026
pulisher
Apr 24, 2026

Apogee Therapeutics Announces Upcoming Board Resignations, Governance Shift - TipRanks

Apr 24, 2026
pulisher
Apr 24, 2026

Apogee Therapeutics (APGE) 2026 meeting to vote on directors, pay and auditor - Stock Titan

Apr 24, 2026
pulisher
Apr 24, 2026

Two directors resign from Apogee Therapeutics (NASDAQ: APGE) board, shrinking it to seven - Stock Titan

Apr 24, 2026
pulisher
Apr 23, 2026

Certain Common Stock of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com

Apr 23, 2026
pulisher
Apr 23, 2026

Certain Pre-Funded Warrants of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com

Apr 23, 2026
pulisher
Apr 23, 2026

Certain Restricted Stock Units of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com

Apr 23, 2026
pulisher
Apr 23, 2026

Apogee Thera (APGE) Stock Price Target | Q4 2025: Earnings Beat EstimatesTrending Volume Leaders - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026
pulisher
Apr 23, 2026

Apogee Therapeutics rises on positive phase 2 data for Zumilokibart in atopic dermatitis - MSN

Apr 23, 2026
pulisher
Apr 23, 2026

APGE (Apogee Therapeutics Inc.) posts narrower Q4 2025 loss than estimates, shares rise modestly after its latest quarterly earnings release.GDR - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026
pulisher
Apr 22, 2026

APGE (Apogee Therapeutics Inc.) Q4 2025 EPS outpaces forecasts, shares gain as investors reward narrower than expected loss.Social Flow Trades - UBND thành phố Hải Phòng

Apr 22, 2026
pulisher
Apr 21, 2026

APGE Earnings History & Surprises | EPS & Revenue Results | APOGEE THERAPEUTICS INC (NASDAQ:APGE) - ChartMill

Apr 21, 2026
pulisher
Apr 20, 2026

Apogee Therapeutics (APGE) CEO exercises options, holds 1.14M shares - Stock Titan

Apr 20, 2026
pulisher
Apr 18, 2026

Apogee Therapeutics stock hits all-time high at 92.48 USD By Investing.com - Investing.com India

Apr 18, 2026
pulisher
Apr 17, 2026

Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therap - GuruFocus

Apr 17, 2026
pulisher
Apr 17, 2026

Apogee Therapeutics CFO Henderson sells $180,000 in stock - Investing.com

Apr 17, 2026
pulisher
Apr 17, 2026

Apogee Therapeutics CFO Henderson sells $180,000 in stock By Investing.com - Investing.com India

Apr 17, 2026
pulisher
Apr 17, 2026

Apogee Therapeutics (APGE) CFO sells 2,000 shares under 10b5-1 plan - Stock Titan

Apr 17, 2026
pulisher
Apr 17, 2026

Apogee Therapeutics stock hits all-time high at 92.48 USD - Investing.com

Apr 17, 2026
pulisher
Apr 15, 2026

Apogee Therapeutics (NASDAQ:APGE) Reaches New 1-Year HighStill a Buy? - MarketBeat

Apr 15, 2026
pulisher
Apr 14, 2026

(APGE) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Apr 14, 2026
pulisher
Apr 13, 2026

Apogee Therapeutics Insider Sold Shares Worth $1,651,664, According to a Recent SEC Filing - Moomoo

Apr 13, 2026
pulisher
Apr 12, 2026

How Investors May Respond To Apogee Therapeutics (APGE) CEO Share Sale and US$403 Million Equity Raise - Sahm

Apr 12, 2026
pulisher
Apr 12, 2026

Apogee Therapeutics Inc. (NASDAQ:APGE) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 12, 2026
pulisher
Apr 11, 2026

Aug PreEarnings: Will Apogee Therapeutics Inc benefit from seasonalityPortfolio Return Report & Expert Approved Trade Ideas - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 10, 2026

Dow Update: Should value investors consider Apogee Therapeutics IncQuarterly Market Summary & Accurate Technical Buy Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Insider Selling: Apogee Therapeutics (NASDAQ:APGE) CEO Sells 20,000 Shares of Stock - MarketBeat

Apr 10, 2026
pulisher
Apr 10, 2026

Apogee Therapeutics CEO Henderson sells $1.65 million in stock By Investing.com - Investing.com Australia

Apr 10, 2026
pulisher
Apr 10, 2026

Apogee Therapeutics CEO Henderson sells $1.65 million in stock - Investing.com

Apr 10, 2026
pulisher
Apr 10, 2026

Apogee Therapeutics (APGE) CEO sells 20,000 shares under Rule 10b5-1 plan - Stock Titan

Apr 10, 2026
pulisher
Apr 10, 2026

Aberdeen Group plc Lowers Stake in Apogee Therapeutics Inc. $APGE - MarketBeat

Apr 10, 2026
pulisher
Apr 09, 2026

Apogee Therapeutics stock hits all-time high at 85.95 USD By Investing.com - Investing.com Australia

Apr 09, 2026
pulisher
Apr 09, 2026

Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month HighStill a Buy? - MarketBeat

Apr 09, 2026
pulisher
Apr 09, 2026

Apogee Therapeutics stock hits all-time high at 85.95 USD - Investing.com

Apr 09, 2026
pulisher
Apr 08, 2026

T. Rowe Price (APGE) discloses 10.29M shares, 16.8% stake in Apogee - Stock Titan

Apr 08, 2026
pulisher
Apr 07, 2026

Trade Recap: Whats the beta of Apogee Therapeutics Inc stockWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn

Apr 07, 2026
$50.73
price down icon 4.01%
$49.38
price down icon 0.52%
$105.46
price down icon 0.09%
$135.30
price up icon 0.61%
$135.17
price down icon 6.02%
ONC ONC
$300.80
price up icon 0.33%
Capitalizzazione:     |  Volume (24 ore):